QQQ   389.91 (+0.72%)
AAPL   163.76 (-0.61%)
MSFT   329.49 (-0.18%)
FB   310.39 (-0.07%)
GOOGL   2,859.32 (+1.36%)
AMZN   3,437.36 (-0.18%)
TSLA   1,084.60 (-0.95%)
NVDA   321.26 (+2.20%)
BABA   122.00 (-0.40%)
NIO   36.20 (-5.51%)
CGC   10.36 (+4.23%)
AMD   150.68 (+1.05%)
GE   95.23 (+2.40%)
MU   82.88 (-2.67%)
T   23.05 (+3.69%)
F   19.87 (+1.48%)
DIS   147.20 (+3.55%)
PFE   53.04 (-3.00%)
AMC   30.28 (+5.99%)
ACB   6.14 (+2.16%)
BA   202.38 (+7.54%)
QQQ   389.91 (+0.72%)
AAPL   163.76 (-0.61%)
MSFT   329.49 (-0.18%)
FB   310.39 (-0.07%)
GOOGL   2,859.32 (+1.36%)
AMZN   3,437.36 (-0.18%)
TSLA   1,084.60 (-0.95%)
NVDA   321.26 (+2.20%)
BABA   122.00 (-0.40%)
NIO   36.20 (-5.51%)
CGC   10.36 (+4.23%)
AMD   150.68 (+1.05%)
GE   95.23 (+2.40%)
MU   82.88 (-2.67%)
T   23.05 (+3.69%)
F   19.87 (+1.48%)
DIS   147.20 (+3.55%)
PFE   53.04 (-3.00%)
AMC   30.28 (+5.99%)
ACB   6.14 (+2.16%)
BA   202.38 (+7.54%)
QQQ   389.91 (+0.72%)
AAPL   163.76 (-0.61%)
MSFT   329.49 (-0.18%)
FB   310.39 (-0.07%)
GOOGL   2,859.32 (+1.36%)
AMZN   3,437.36 (-0.18%)
TSLA   1,084.60 (-0.95%)
NVDA   321.26 (+2.20%)
BABA   122.00 (-0.40%)
NIO   36.20 (-5.51%)
CGC   10.36 (+4.23%)
AMD   150.68 (+1.05%)
GE   95.23 (+2.40%)
MU   82.88 (-2.67%)
T   23.05 (+3.69%)
F   19.87 (+1.48%)
DIS   147.20 (+3.55%)
PFE   53.04 (-3.00%)
AMC   30.28 (+5.99%)
ACB   6.14 (+2.16%)
BA   202.38 (+7.54%)
QQQ   389.91 (+0.72%)
AAPL   163.76 (-0.61%)
MSFT   329.49 (-0.18%)
FB   310.39 (-0.07%)
GOOGL   2,859.32 (+1.36%)
AMZN   3,437.36 (-0.18%)
TSLA   1,084.60 (-0.95%)
NVDA   321.26 (+2.20%)
BABA   122.00 (-0.40%)
NIO   36.20 (-5.51%)
CGC   10.36 (+4.23%)
AMD   150.68 (+1.05%)
GE   95.23 (+2.40%)
MU   82.88 (-2.67%)
T   23.05 (+3.69%)
F   19.87 (+1.48%)
DIS   147.20 (+3.55%)
PFE   53.04 (-3.00%)
AMC   30.28 (+5.99%)
ACB   6.14 (+2.16%)
BA   202.38 (+7.54%)
OTCMKTS:VTXPF

Victrex Stock Forecast, Price & News

$31.00
0.00 (0.00%)
(As of 12/1/2021 12:00 AM ET)
Add
Compare
Today's Range
$31.00
$31.00
50-Day Range
$30.32
$35.99
52-Week Range
$27.52
$36.50
Volume
44 shs
Average Volume
1,014 shs
Market Capitalization
$2.68 billion
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.17
30 days | 90 days | 365 days | Advanced Chart
Receive VTXPF News and Ratings via Email

Sign-up to receive the latest news and ratings for Victrex and its competitors with MarketBeat's FREE daily newsletter.


Victrex logo

About Victrex

Victrex Plc is a holding company, which engages in the manufacture and marketing of polymers. It operates through the Industrial and Medical segments. The Industrial segment focuses on the automotive, aerospace, electronics, and energy markets. The Medical segment offers specialist solutions for medical device manufacturers. The company was founded on February 25, 1993 and is headquartered in Thornton Cleveleys, the United Kingdom.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Private households
Sub-Industry
N/A
Current Symbol
OTCMKTS:VTXPF
Previous Symbol
NASDAQ:VTXPF
CIK
N/A
Employees
874
Year Founded
N/A

Sales & Book Value

Annual Sales
$339.29 million
Cash Flow
$1.26 per share
Book Value
$7.09 per share

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
$2.68 billion
Optionable
Not Optionable

Company Calendar

Today
12/02/2021
Fiscal Year End
9/30/2022

MarketRank

Overall MarketRank

1.59 out of 5 stars

Analyst Opinion: 2.2Community Rank: 3.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -












Victrex (OTCMKTS:VTXPF) Frequently Asked Questions

Is Victrex a buy right now?

11 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Victrex in the last year. There are currently 1 sell rating, 4 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" Victrex stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in VTXPF, but not buy additional shares or sell existing shares.
View analyst ratings for Victrex
or view top-rated stocks.

How has Victrex's stock price been impacted by COVID-19 (Coronavirus)?

Victrex's stock was trading at $25.40 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, VTXPF shares have increased by 22.0% and is now trading at $31.00.
View which stocks have been most impacted by COVID-19
.

What price target have analysts set for VTXPF?

11 equities research analysts have issued 1-year target prices for Victrex's shares. Their forecasts range from $36.32 to $36.32. On average, they expect Victrex's share price to reach $36.32 in the next year. This suggests a possible upside of 17.2% from the stock's current price.
View analysts' price targets for Victrex
or view top-rated stocks among Wall Street analysts.

Who are Victrex's key executives?

Victrex's management team includes the following people:
  • Jakob O. Sigurðsson, Chief Executive Officer & Executive Director
  • Kenny Gilmour, Operations Director
  • Richard James Armitage, Group Finance Director & Executive Director
  • Martin Court, Executive Director & Chief Commercial Officer
  • Andrew Hanson, Director-Investor Relations & Communications

What is Victrex's stock symbol?

Victrex trades on the OTCMKTS under the ticker symbol "VTXPF."

How do I buy shares of Victrex?

Shares of VTXPF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Victrex's stock price today?

One share of VTXPF stock can currently be purchased for approximately $31.00.

How much money does Victrex make?

Victrex has a market capitalization of $2.68 billion and generates $339.29 million in revenue each year.

How many employees does Victrex have?

Victrex employs 874 workers across the globe.

What is Victrex's official website?

The official website for Victrex is www.victrexplc.com.

Where are Victrex's headquarters?

How can I contact Victrex?

Victrex's mailing address is Hillhouse International Thornton Cleveleys, Lancashire X0, FY5 4QD. The company can be reached via phone at 441253897700, via email at [email protected], or via fax at 44-12-5389-7701.


This page was last updated on 12/2/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.